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Abstract 
The additive, a natural mixture of dolomite plus magnesite and magnesium-phyllosilicates, is intended 
to be used as a technological additive (functional groups: anticaking agents) in feedingstuffs for all 
animal species. The additive is safe in complete feed for dairy cows, piglets and pigs for fattening at a 
maximum concentration of 20,000 mg/kg. No conclusions can be drawn for all the other animal 
species/categories. The additive is not genotoxic. As the additive is essentially not absorbed from the 
gut lumen, the Panel on Additives and Products or Substances used in Animal Feed considers that use 
of the additive in animal nutrition is safe for consumers of food products from animals fed diets 
containing the additive. The additive is not an irritant to the eyes and the skin, it is not a skin 
sensitiser and it is of low toxicity by the inhalation route. The components of the additive (dolomite, 
magnesite, talc and chlorite) are natural constituents of soil. Consequently, the use of the additive in 
animal nutrition will not pose a risk to the environment. The additive is effective as an anticaking 
agent at a minimum inclusion level of 5,000 mg/kg feed. 
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Summary 
Following a request from the European Commission, the Panel on Additives and Products or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and 
efficacy of the a natural mixture of dolomite plus magnesite and magnesium-phyllosilicates. 
The additive is safe in complete feed for dairy cows, piglets and pigs for fattening at a maximum 
concentration of 20,000 mg/kg. No conclusions can be drawn for all the other animal 
species/categories. 
The additive is not genotoxic. As the additive is essentially not absorbed from the gut lumen, the 
FEEDAP Panel considers that use of the additive in animal nutrition is safe for consumers of food 
products from animals fed diets containing the additive. 
The additive is not an irritant to the eyes and the skin, it is not a skin sensitiser and it is of low toxicity 
by the inhalation route. 
The components of the additive (dolomite, magnesite, talc and chlorite) are natural constituents of 
soil. Consequently, the use of the additive in animal nutrition will not pose a risk to the environment. 
The additive is effective as an anticaking agent at a minimum inclusion level of 5,000 mg/kg feed.  
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1. Introduction  
1.1. Background and Terms of Reference  
 
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of 
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any 
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an 
application in accordance with Article 7.  
The European Commission (EC) received a request from IMI FABI S.p.A.2 for authorisation of the 
product natural mixture of dolomite plus magnesite and magnesium-phyllosilicates (Fluidol), when 
used as a feed additive for all animal species (category: technological additives; functional group: 
anticaking agents).  
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the application 
to the European Food Safety Authority (EFSA) as an application under Article 4(1) (authorisation of a 
feed additive or new use of a feed additive). The particulars and documents in support of the 
application were considered valid by EFSA as of 6 August 2013. 
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and 
documents submitted by the applicant, shall undertake an assessment in order to determine whether 
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on 
the safety for the target animals, consumer, user and the environment and on the efficacy of the 
product natural mixture of dolomite plus magnesite and magnesium-phyllosilicates (Fluidol), when 
used under the proposed conditions of use (see Section 3.1.6). 
1.2. Additional information  
The additive Fluidol is a natural mixture of dolomite plus magnesite and magnesium-phyllosilicates 
(chlorite and talc). This product has not been previously authorised in the Community. 
2. Data and Methodologies  
2.1. Data 
The present assessment is based on data submitted by the applicant in the form of a technical 
dossier3 in support of the authorisation request for the use of natural mixture of dolomite plus 
magnesite and magnesium-phyllosilicates (Fluidol) as a feed additive. The technical dossier was 
prepared following the provisions of Article 7 of Regulation (EC) No 1831/2003 and the applicable 
EFSA guidance documents. 
The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) used the data 
provided by the applicant together with data from other sources, such as previous risk assessments by 
EFSA or other expert bodies and peer-reviewed scientific papers, to deliver the present output.  
EFSA has verified the European Union Reference Laboratory (EURL) report as it relates to the 
methods used for the control of the active substance in animal feed. The Executive Summary of the 
EURL report can be found in Annex A.4 
2.2. Methodologies 
The approach followed by the FEEDAP Panel to assess the safety and the efficacy of natural mixture 
of dolomite plus magnesite and magnesium-phyllosilicates is consistent with the principles laid down 
                                                          
1  Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in 
animal nutrition. OJ L 268, 18.10.2003, p. 29. 
2    IMI FABI S.p.A. Viale dei Mille, 68, 20129 Milano, Italy. 
3   FEED dossier reference: FAD-2012-0043. 
4   The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/default/files/FinRep-FAD-2012- 
    0043%20Fluidol.doc_.pdf   
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in Regulation (EC) No 429/20085 and the relevant guidance documents: Guidance on technological 
additives (EFSA FEEDAP Panel, 2012a), Technical guidance: Tolerance and efficacy studies in target 
animals (EFSA FEEDAP Panel, 2011), Guidance for establishing the safety of additives for the 
consumer (EFSA FEEDAP Panel, 2012b) and Guidance on studies concerning the safety of use of the 
additive for users/workers (EFSA FEEDAP Panel, 2012c). 
3. Assessment 
The product under assessment is a natural mixture mainly composed dolomite, magnesite, and 
magnesium-phyllosilicates (talc and chlorite), subsequently referred to as MDMM. Talc is authorised 
for use as food additive under Regulation (EC) No 1333/2008,6 with a specification established by 
Regulation (EU) No 231/2012.7 
The applicant is seeking an authorisation for the use of the product as a technological additive 
(functional groups: (i) anticaking agents) in feedingstuffs for all animal species.  
3.1. Characterisation 
References to the dossier in the footnotes should read as in the examples below. 
3.1.1. Characterisation of the additive 
The product is obtained by mining from a quarry located in Italy. Extraction is followed by crushing, 
drying and packaging. It is a grey fine powder clay with a bulk density of about 820 kg/m3.8   
The product is specified to contain at least 40% of dolomite plus magnesite as main components; the 
other components are magnesium-phyllosilicates (hydrated silicates of magnesium (talc) and of 
aluminium–magnesium (chlorite)). The additive is further specified to contain at least 24% carbonates 
and to be free of quartz and asbestos. The characteristics of the main constituents are listed in Table 
1. 
Table 1:  Main characteristics of the additive dolomite plus magnesite and magnesium-phyllosilicates 
as provided by the applicant. 
 Dolomite Magnesite Talc Chlorite 
CAS number 16389-88-1 546-93-0 14807-96-6 1318-59-8 
EINECS number 240-440-2 208-915-9 238-877-9 215-285-9 
Chemical formula (CaMg)(CO3)2K(Al,Fe)2AlSi3O10(OH)2.H2O 
MgCO3Nax[(Al2-
xMgx)Si4O10)(OH)2] 
Mg3Si4O10(OH)2Al2
(OH)4(SiO5) 
(Mg, Fe, Al)6(Si, 
Al)4O10(OH)8 
X-ray diffraction (XRD) is commonly used to provide a full mineralogical analysis of clays, which can 
also be characterised by their elemental composition, usually determined/expressed as the 
corresponding oxides. Both mineralogical and chemical approaches have been used to characterise 
the additive. The mineralogical composition (XRD of six batches)9 is summarised in Table 2. The 
                                                          
5 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC) No 
1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications and 
the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1. 
6 Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives (OJ L 
354, 31.12.2008, p. 16)   
7 Commission Regulation (EU) No 231/2012 of 9 March 2012 laying down specifications for food additives listed in Annexes II 
and III to Regulation (EC) No 1333/2008 of the European Parliament and of the Council. (O J L 83, 22.3.2012, p. 1–295) 
8 Technical dossier/Section II/Annex 2-1-10  
9 Technical dossier/Section II/Annex 2-1-1 and Supplementary Information July 2014/Annex i_1 
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elemental composition (six batches)10 is given in Table 3. Asbestos11 and crystalline silica (quartz, 
tridymite and cristobalite)12 were absent in three batches of the additive. 
Table 2:  Mineralogical composition of six batches of the product (X-ray diffraction). 
 
Dolomite 
(%) 
Magnesite 
(%) 
Talc 
(%) 
Chlorite 
(%) 
Mean  29 18 36 17 
Minimum 26 14 35 16 
Maximum  33 21 37 18 
Table 3:  Elemental composition of five batches of the product (expressed as oxide) 
 
SiO2 
(%) 
MgO 
(%) 
Fe2O3 
(%) 
CaO 
(%) 
Al2O3  
(%) 
Mean  28.4 27.8 8.1 5.1 2.5 
Minimum 27.9 27.0 7.8 4.9 2.1 
Maximum  28.8 28.4 8.4 5.4 2.7 
The product is further characterised by (average of three batches) loss of ignition (900°C): 27.1%;13 
pH (10% solution): 8.5 – 9.0;14 moisture (4 h at 105°C): 0.15%;15 carbonates: > 24%.16 
3.1.2. Purity 
Three batches of the product17 showed concentrations of lead, cadmium, mercury and arsenic below 
the respective limit of detections (≤ 5 mg/kg, ≤ 1 mg/kg, ≤ 0.1 mg/kg and ≤ 1 mg/kg, respectively) 
and that do not raise safety concern. 
Dioxins in four batches were ≤ 0.06 ng WHO PCDD/F-TEQ/kg, sum of dioxins and dioxins-like 
polychlorinated biphenyls (PCBs) ≤ 0.09 ng WHO-PCDD/F-PCB-TEQ/kg and of non-dioxin-like PCBs 
(ICES = 6) ≤ 0.33 μg/kg.18 These concentrations are below the limits set in the Commission Directive 
2002/32/EC.19 
3.1.3. Physical state of the product 
Particle size distribution, analysed by laser diffraction in three batches of the additive,20 showed that 
about 97% of particles (v/v) were ≤ 100 µm, 85% ≤ 50 µm and 45% ≤ 10 µm. The mean diameter 
of the particles of the additive was about 12 µm. 
The additive showed a dusting potential (analysed by Stauber–Heubach method in three batches)21 of 
about 10 g/m3. 
3.1.4. Stability and homogeneity 
Stability studies are not required for mineral-based products, which are assumed to be stable.  
                                                          
10 Technical dossier/Section II/Annex 2-1-2 
11 Technical dossier/Section II/Annex 2-1-5 
12 Technical dossier/Section II/Annex 2-1-6 
13 Technical dossier/Section II/Annex 2-2-1  
14 Technical dossier/Section II 
15 Technical dossier/Section II/Annex 2-2-2  
16 Technical dossier/Section II 
17 Technical dossier/Section II/Annex 2-1-3  
18 Technical dossier/Section II/Annex 2-1-4  
19 Directive 2002/32/EC of the European Parliament and of the Council as regards maximum levels and action thresholds for 
dioxins and polychlorinated biphenyls (OJ L 140, 30.5.2002, p.10) 
20 Technical dossier/Section II/Annex 2-1-8  
21 Technical dossier/Section II/Annex 2-1-9  
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For an additive intended as an anticaking agent, no homogeneity studies are considered necessary if 
the efficacy can be demonstrated (see Section 3.3).  
3.1.5. Physico-chemical interactions in feed 
An in vitro trial was performed22 to study the effect of the additive on the analytical determination of 
different diet components. The additive was added at concentrations of 1.6% to mash and pelleted 
feeds for poultry, piglets and cattle for fattening. The feeds (control and treated with the additive) 
were then analysed for concentrations of basic nutrients of the diets,23 macro and trace elements,24 
vitamins and amino acids25, and of coccidiostats.26 The results showed that the analytical recovery of 
the tested constituents was not affected by the additive. No physico-chemical incompatibilities with 
feed materials, other additives or medicinal substances in feed are therefore expected. 
3.1.6. Conditions of use 
The additive is intended to be used in premixtures and feedingstuffs for all animal species and 
categories, with no minimum and maximum content. The applicant suggested use levels in 
premixtures and feedingstuffs of 5,000 – 20,000 mg/kg.  
3.2. Safety 
3.2.1. Safety for the target species 
Safety for weaned piglets 
A total of 96 male piglets (Pietrain × (Large white × Landrace)) of about 26 days of age was fed 
pelleted diets supplemented with 0, 20,000 (1 × the highest recommended use level) or 100,000 
(5×) mg MDMM/kg for 42 days.27 Group size was eight replicates with four piglets each (initial body 
weight: 8.3 kg). The diets consisting mainly of barley, maize, biscuit meal and soybean meal were 
isonitrogenous (about 18% crude protein (CP)) and isocaloric (about 10 MJ net energy (NE)/kg, by an 
increase of animal fat with increasing content of the additive). The concentrations of the additive were 
analytically confirmed (by analysis of iron). Body weight (bw) and feed intake were recorded 
fortnightly. Feed-to-gain ratio was calculated for the different periods. At the end of the experiment, a 
blood sample was taken from two piglets per pen for haematology28 and clinical chemistry.29 The 
experiment was statistically considered as a randomised complete block design with the pen as 
experimental unit. The effects of the additive were evaluated by a set of linear contrasts. Group 
differences were analysed by Duncan’s multiple range test. 
No mortality occurred. Final body weight of the control was 30.7 kg and average daily weight gain 
was 511 g, both not being significantly different from the two MDMM treated groups. Feed-to-gain 
ratio of the control and of the groups receiving 20,000 and 100,000 mg MDMM/kg feed was 1.43, 
1.44 and 1.46, respectively.  
Among the blood biochemical parameters, differences between groups were seen for serum 
phosphorus, for AP, ALT and for β-globulins. They were not treatment related. Haematology 
did not show differences between the groups except the relative white blood cell 
                                                          
22 Technical dossier/Section II/Annex 2-4-2  
23 Moisture, ash, crude cellulose, crude protein, crude fat, starch, total sugar, metabolisable energy 
24 Calcium, sodium, phosphorus, iron, zinc, copper, manganese, cobalt, iodine, selenium 
25 Vitamin A, vitamin E, vitamin D3, lysine, methionine, methionine hydroxy analogue 
26 Monensin sodium, narasin, salinomycin sodium, decoquinate, diclazuril, halofuginone, lasalocid a sodium, maduramycin 
ammonium alpha, nicarbazin, robenidine hydrochloride, semduramicin sodium. 
27 Supplementary Information July 2014/Annex_ii_2 A-D. 
28  Haemoglobin (Hb), red blood cell count (RBC), packed cell volume (PCV), mean corpuscular volume (MCV), mean corpuscular 
haemoglobin (MCH), platelets, white blood cell count (WBC), white blood cell differentials (segmented neutrophils, banded 
neutrophils, lymphocytes, monocytes, eosinophils). 
29  Alanine transaminase (ALT), alkaline phosphatase, aspartate aminotransferase (AST), creatine phosphokinase (CPK), gamma-
glutamyltranspeptidase (GGT), glutamate dehydrogenase (GLDH), glutathione peroxidase (GSH-Px), lactate dehydrogenase 
(LDH), albumins, globulins, total protein, glucose, urea, phosphate. 
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differentials, where minor and not treatment related differences were observed. In total, 
there was evidence that 100,000 mg MDMM/kg feed was tolerated by piglets.  
Safety for chickens for fattening 
A total of 960 one-day-old male chickens (Ross 308) was fed pelleted diets supplemented with 0, 
20,000 (1 × the highest recommended use level), 50,000 (2.5 ×) or 100,000 (5 ×) mg MDMM/kg for 
35 days.30 Group size was 6 replicates with 40 birds each. The diets (starter, from day 0 to day 21; 
grower, from day 22 to day 35) consisting mainly of maize and soybean meal, were isonitrogenous 
(starter: about 21.5% CP; grower: about 19.5% CP) and isocaloric (starter: about 12.3 MJ ME/kg; 
grower: about 12.8 MJ/kg, by an increase of full fat extruded soybeans with increasing content of the 
additive). The concentration of the additive was analytically confirmed (by analysis of iron). The diets 
contained 0.05% of a coccidiostat (monensin sodium); the starter diet included also 0.5% titanium 
oxide, used as an inert marker for the digestibility measurements. Body weight and feed intake were 
recorded at day 21 and at day 35. Feed-to-gain ratio was calculated for the different periods. At the 
end of the experiment, a blood sample was taken from one chicken per pen for haematology31 and 
clinical chemistry.32 On days 18 to 21, excreta samples were collected for the determination of 
nitrogen and uric acid, vitamin E (tocopherol acetate, alpha tocopherol and total tocopherols), 
riboflavin, pyridoxine, zinc and monensin, and the digestibility was calculated for the groups receiving 
0 and 20,000 mg MDMM/kg feed. The experiment was statistically considered as a randomised 
complete block design with the pen as experimental unit. The effects of the additive were evaluated 
by a set of linear contrasts. Group differences were analysed by Duncan’s multiple range test. 
Overall mortality was low but it increased from 1.2% in the control to 4.0% in the 100,000 mg 
MDMM/kg group. A linear trend was not significant (p = 0.052). The mean final body weight of the 
control was 2.64 kg, average daily feed intake 109 g. The significant differences observed within the 
final body weight, average daily gain refer to lower values for the high dose group compared to the 
mid dose group, but not to the control group. Feed intake was significantly higher in the mid dose 
group compared to the control group. With increasing amount of MDMM, feed-to-gain ratio increased 
too. The control group (1.44) was significantly better than all treated groups, the low and mid dose 
groups (1.46 and 1.48, respectively) were not different, the highest value (1.51) was calculated for 
the highest level group, and was significantly different from all the other groups.  
The only haematological parameter which appeared to be affected by MDMM was the increased 
number of leucocytes and basophils, both showing a significant trend. However, these differences 
reached significance only in the highest group (26.2 × 103/µL vs. 19.3 × 103/µL for leucocytes, 
2491 vs. 684 for basophils). No safe level of MDMM for chickens for fattening could be identified since 
feed-to-gain ratio was higher in all treated groups compared to control. 
The excretion of nitrogen, tocopherol acetate, alpha tocopherol and total tocopherols, riboflavin, 
pyridoxine, zinc was not significantly affected by the additive in concentration of 20,000 mg 
MDMM/kg. Monensin sodium showed a small but significant reduction in digestibility (95% vs 94%). 
Safety for dairy cows 
A total of 60 Holstein multiparous cows (initial average days in milk: 178 days) was fed total mixed 
ration (TMR) mainly composed of alfalfa hay, sorghum silage and concentrate supplemented with 0, 
20,000 (1 × the highest recommended use level), 50,000 (2.5 ×) or 100,000 (5 ×) mg MDMM/kg for 
58 days.33 Group size was 15 cows fed together in one pen. The diets were calculated to be 
isonitrogenous (about 15.5% CP) and isocaloric (about 6.7 MJ net energy for lactation (NEL)/kg), the 
increasing content of the additive was compensated by an increase of soybean meal and maize grain. 
It is noted that the incorporation 10% MDMM in an isonitrogenous and isocaloric diet involved many 
changes in the diet composition that the comparability of this diet with the three others is 
                                                          
30 Supplementary Information July 2015/Annex_ii_1_A-D 
31 Haemoglobin (Hb), red blood cell count (RBC), packed cell volume (PCV), mean corpuscular volume (MCV), mean corpuscular 
haemoglobin (MCH), platelets, white blood cell count (WBC), white blood cell differentials (segmented neutrophils, banded 
neutrophils, lymphocytes, monocytes, eosinophils). 
32 Alanine transaminase (ALT), alkaline phosphatase, aspartate aminotransferase (AST), creatine phosphokinase (CPK), gamma-
glutamyltranspeptidase (GGT), glutamate dehydrogenase (GLDH), glutathione peroxidase (GSH-Px), lactate dehydrogenase 
(LDH), albumins, globulins, total protein, glucose, uric acid, phosphate. 
33 Supplementary Information July 2015/Annex_i_1_A-D 
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questionable. The concentration of the additive was analytically confirmed (by analysis of iron). Group 
feed intake and individual milk production were recorded daily. Milk composition (fat and protein) 
were analysed at day 20 and 56. At the end of the experiment, a blood sample was taken from seven 
animals per treatment for haematology34 and clinical chemistry.35 All data, with the exception of group 
feed intake, were analysed with a mixed model considering the data from the different periods and 
the effect of the animal, with the animal as experimental unit.  
No significant difference in milk yield between the control and the 20,000 and 50,000 mg MDMM/kg 
feed group was observed, but there was a significant reduction (p < 0.05) in the group given the 
highest dose (control: 30.8 kg; 100,000 mg MDMM/kg feed group: 29.4 kg). Although the group 
determination of feed intake did not allow a statistical analysis, the reduction in milk yield appeared to 
be associated with a reduction in the dry matter (DM) intake (control: 23.4 kg DM/day; 100,000 mg 
MDMM/kg feed group: 22.3 kg DM/day). In general, milk fat (control: 4.03%) and protein (control: 
3.50%) were not influenced by the treatment, although there were some significant group 
differences. 
No differences were found among haematological parameters. Blood electrolytes showed some 
significant differences. Significant differences in blood magnesium are limited to differences between 
the control value and the mid dose group (2.6 and 2.78 mg/100 mL, respectively); as well as the 
significant differences observed in sodium and chloride, they are not considered treatment related. 
Blood urea concentration was nearly the same in the control and in the low-dose groups (26.0 and 
26.7 mg/100 mL, respectively). Similar values were found for the mid- and the high-dose groups (23.5 
and 23.1 mg/100 mL). The differences between the two pairs of groups are considered to be diet 
related and not treatment related. Blood creatinine increased with MDMM addition in a dose-
dependent manner. The absence of difference in any of the other parameters of clinical biochemistry 
would suggest that the changes in the creatinine level observed are not related to tissue damage.  
Significant decrease in milk yield in the high-dose group compared to the control group, and the low- 
and mid-dose groups is considered adverse. The evident differences in the rations formulation 
between control and low-dose groups on one side, and the mid- and high-dose group on the other 
make it difficult to conclude on the safety of 50,000 mg MDMM/kg feed. Therefore, only an MDMM 
concentration of 20,000 mg/kg complete feed for dairy cows is considered safe. 
Interactions in vivo 
The excretion of nitrogen, tocopherol acetate, alpha tocopherol and total tocopherols, riboflavin, 
pyridoxine, zinc was not significantly affected by the additive in concentration of 20,000 mg MDMM/kg 
in diets for chickens for fattening. It is expected that the additive, up to a concentration of 
50,000 mg/kg complete feed, will not interfere with the nutrient/micronutrients supply of animals. 
Conclusions on the safety for target species 
All three studies had deficiencies in their design. The chicken and the piglet study did not include data 
on plasma electrolytes, although an interaction with the mineral clay might be anticipated. In the 
study on dairy cows, feed intake could not be replicated and the efforts to formulate isocaloric diets 
resulted in substantially different diets. Therefore, only limited conclusions on the safety of the 
additive could be drawn from these studies.  
MDMM in chickens for fattening up to 20,000 mg/kg feed did not influence the absorption of 
nutrients/micronutrients.  
The proposed supplementation level of MDMM (20,000 mg MDMM/kg complete feed) is considered 
safe dairy cows and for piglets (weaned). This conclusion is extended to pigs for fattening. No 
conclusion can be drawn on the safety for poultry or any other species/categories. 
                                                          
34  Haemoglobin (Hb), red blood cell count (RBC), packed cell volume (PCV), mean corpuscular volume (MCV), mean corpuscular 
haemoglobin (MCH), platelets, white blood cell count (WBC), white blood cell differentials (neutrophils, lymphocytes, 
monocytes, eosinophils, basophils). 
35  Alanine transaminase (ALT), alkaline phosphatase, aspartate aminotransferase (AST), creatine phosphokinase (CPK), gamma-
glutamyltranspeptidase (GGT), glutamate dehydrogenase (GLDH), glutathione peroxidase (GSH-Px), lactate dehydrogenase 
(LDH), calcium, phosphorous, magnesium, potassium, chlorine, cholesterol, lactate, albumins, total protein, urea, creatinine 
and non-esterified fatty acids. 
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3.2.2. Safety for the consumer 
The FEEDAP Panel considers it unlikely that dolomite, magnesite, talc and chlorite, in common with 
other clays, will be degraded during their passage through the gastrointestinal tract of target animals 
or absorbed to any measurable extent and that harmful amounts of residues of any chemical 
component would occur in edible tissues/products as a consequence of the use of the additive.  
The applicant has provided some reports of toxicological studies performed with the additive.  
The additive was tested for mutagenicity in a bacterial reverse mutation test. The study was good 
laboratory practice (GLP) compliant and conformed to OECD Guideline 471.36 It used concentrations of 
the additive of up to 5,000 µg/plate in two independent experiments, using strains TA1537, TA1535, 
TA98, TA100 and TA102 of Salmonella Typhimurium in the presence and absence of S9 from the 
livers of rats treated with Aroclor 1254. None of the strains showed any evidence of mutagenesis in 
either the presence or absence of metabolic activation. Positive control chemicals gave the expected 
results for each tester strain. 
MDMM was tested in an in vitro chromosome aberration test in human lymphocytes. The study was 
GLP compliant and conformed to OECD Guideline 473 (version 1997).37 Based on the results of a 
preliminary cytotoxicity test, 1,500 μg/mL was selected as the highest concentration to be tested, 
both in the presence and in the absence metabolic activation (S9 mix from liver of rats treated with 
Aroclor 1254). Fluidol did not induce any statistically significant increase in the number of cells with 
chromosome aberrations, polyploidy or endoreduplication, in any experimental condition at treatment 
levels causing evident cytotoxicity (52% reduction of mitotic index at 1,000 μg/mL without S9 mix; 
54% at 1,300 μg/mL with S9 mix). Positive control chemicals produced the expected results. 
The micronucleus test was GLP compliant and conformed to OECD Guideline 474.38 Five male and five 
female Swiss albino mice were used per experimental groups. Animals were treated orally (by gavage) 
with the limit dose of 2,000 mg/kg body weight using two treatments separated by 24 h. Toxicity to 
bone marrow (as indicated by the polychromatic to total erythrocytes ratio) was not seen in the group 
treated with the additive, therefore, there was no evidence of target exposure. There was no increase 
in the number of micronucleated polychromatic erythrocytes seen in the bone marrow of the additive-
treated group. The positive control group responded as expected. 
Conclusions on safety for the consumer 
The additive is not genotoxic. As the additive is essentially not absorbed from the gut lumen, the 
FEEDAP Panel considers that use of MDMM in animal nutrition is safe for consumers of food products 
from animals fed diets containing the additive. 
3.2.3. Safety for the user 
Effects on the respiratory system 
The additive has a high dusting potential (10 g/m3) and contains a high proportion of fine particles 
(85% ≤ 50 µm diameter; 45% ≤ 10 µm). Therefore, there is a potential for all parts of the respiratory 
tract of workers to be exposed by inhalation of dust generated as a result of handling of the additive.  
An acute inhalation toxicity study was performed with the additive using groups of three male and 
three female Wistar rats exposed to 0 or 4.2 mg additive/L air for 4 h followed by a recovery period of 
14 days, using a protocol that conformed to OECD Guideline 403.39 No adverse effects on signs of 
toxicity, body weight or gross pathology were found. Therefore, the additive is considered to be of low 
toxicity by the inhalation route. 
                                                          
36 Technical dossier/Section III/Annex 3-2-2  
37 Technical dossier/Section III/Annex 3-2-3  
38 Technical dossier/Section III/Annex 3-2-4  
39 Technical dossier/Section III/Annex 3-3-1  
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Effects on eyes and skin 
An acute dermal toxicity study conforming to OECD Guideline 402 was performed on the additive 
using groups of 10 male and 10 female Wistar rats.40 No mortality was observed. No adverse effects 
on signs of toxicity, body weight or gross pathology were found. Therefore, the additive is considered 
to be of low toxicity by the dermal route. 
Acute dermal irritation and eye irritation studies with MDMM were performed in New Zealand White 
rabbits conforming to OECD Test Guideline 404 and 405.41,42 Both the studies were GLP compliant. In 
the dermal study, slight erythema and very slight oedema were seen in all animals at 24 and 48 h but 
all application sites were normal at 72 h. The control application sites remained normal throughout the 
study. The only reaction in treated eyes was a slight transient redness. All eyes appeared normal at 
72-h postdosing. The results of these tests indicate that the additive does not require labelling as a 
skin or an eye irritant. 
Skin sensitisation was investigated in male Hartley strain guinea-pigs using a Magnusson and Kligman 
test that conformed to OECD Test Guideline 406.43 The study was GLP compliant. There were no signs 
of toxicity in any animals and body weight was unaffected by treatment. No skin reactions were seen 
in any of the animals at 24 or 48 h after patch removal. Thus the study results indicated that Fluidol is 
not a skin sensitiser. 
Conclusions on safety for the user 
The additive is not an irritant to the skin or the eyes, it is not a dermal sensitiser and it is of low 
toxicity by the inhalation route. 
3.2.4. Safety for the environment 
The components of the additive (dolomite, magnesite, talc and chlorite) are ubiquitous in the 
environment, being natural components of soil. Therefore, it is not expected that its use as a feed 
additive would adversely affect the environment. 
3.3. Efficacy 
The efficacy of the additive as anticaking agent was tested in five subsamples each of a laying hen44 
and a cattle45 pelleted feed (pellet dimensions 3 × 8 and 4 × 23 mm, respectively) and a crumbled 
pig46 feed. After mixing the feeds with the additive at concentrations of 0, 5,000, 10,000 and 
20,000 mg/kg, samples of 500 g each were loaded in a standard cone with an orifice of 18 mm (laying 
hens and pig feed) or 43 mm (cattle feed) and left to fall from a standard height of 80 mm (laying 
hens and cattle feed) and 95 mm (pig feed). Below the cone the sample formed a small pile, forming 
an angle of response D, calculated as a quotient of the height (h) and the diameter (D) of the pile 
(tan D = h/0.5D). The measure of the angle gives the tendency of the material to be cohesive or free-
flowing, with lower values (25–30°) for very flowing materials and higher values (> 66°) for cohesive 
materials (Carr, 1965). The speed of flow through the cone (S) gives an indication of the flowability; 
the data were statistically analysed using Student’s t-test to compare the series.  
In the three feedingstuffs tested, the addition of 0, 5,000, 10,000 and 20,000 mg MDMM/kg improved 
the flowability of feed (Table 4) as indicated by lower values for the angle of response α and the 
reduced flow time (speed S). 
  
                                                          
40 Technical dossier/Section III/Annex 3-3-3  
41 Technical dossier/Section III/Annex 3-3-4 
42 Technical dossier/Section III/Annex 3-3-2  
43 Technical dossier/Section III/Annex 3-3-5 
44 Technical dossier/Section IV/Annex 4-1-A and Annex  4-1-B 
45 Technical dossier/Section IV/Annex 4-3-A and Annex 4-3-B  
46 Technical dossier/Section IV/Annex 4-2-A and Annex 4-2-B 
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Table 4:  Efficacy of the additive as an anticaking agent in feedingstuffs for laying hens, cattle and 
pigs.  
Feedingstuffs  Inclusion level (mg/kg) 
 0 5,000 10,000 20,000 
Laying hens      
Angle of response D (°) 41.6 41.3* 39.2** 37.2** 
Speed of flow S (s) 11.2 10.8* 10.4** 9.9** 
Cattle      
Angle of response D (°) 31.6 30.3* 29.9* 29.2** 
Speed of flow S (s) 14.3 13.3* 13.4* 12.5** 
Pigs     
Angle of response D (°) 42.6 41.9* 41.3** 40.4** 
Speed of flow S (s) 22.9 22.2** 21.9** 21.7** 
*,** Means within a row with stars are significantly different from the control (*p ≤ 0.05; **p ≤ 0.01) 
In the three feedingstuffs tested, the addition of 5,000, 10,000 and 20,000 mg/kg of the additive 
improved the flowability of feed as indicated by lower values for the angle of response D and the 
reduced flow time (speed S). 
4. Conclusions 
The additive is safe in complete feed for dairy cows, piglets and pigs for fattening at a maximum 
concentration of 20,000 mg/kg. No conclusions can be drawn for all the other animal 
species/categories. 
The additive is not genotoxic. As the additive is essentially not absorbed from the gut lumen. The 
FEEDAP Panel considers that use of MDMM in animal nutrition is safe for consumers of food products 
from animals fed diets containing the additive. 
The additive is not an irritant to the eyes and the skin, it is not a skin sensitiser and it is of low toxicity 
by the inhalation route. 
The components of the additive (dolomite, magnesite, talc and chlorite) are natural constituents of 
soil. Consequently, the use of the additive in animal nutrition will not pose a risk to the environment. 
The additive is effective as an anticaking agent at a minimum inclusion level of 5,000 mg/kg feed. 
5. Remark 
The FEEDAP Panel notes that the iron content of the product (average 5.7% and ranges between 
5.5% and 5.9%) would limit its use in compound feedingstuffs for which a maximum content for iron 
is set by the EU legislation.47 
Documentation provided to EFSA  
1. Natural mixture of dolomite plus magnesite and magnesium-phyllosilicates (Fluidol) for all animal 
species. November 2012. Submitted by IMI FABI S.p.A. 
2. Natural mixture of dolomite plus magnesite and magnesium-phyllosilicates (Fluidol) for all animal 
species. Supplementary information. July 2014. Submitted by IMI FABI S.p.A. 
3. Natural mixture of dolomite plus magnesite and magnesium-phyllosilicates (Fluidol) for all animal 
species. Supplementary information. July 2015. Submitted by IMI FABI S.p.A. 
4. Evaluation report of the European Union Reference Laboratory for Feed Additives on the 
                                                          
47 Commission Regulation (EC) No 1334/2003 of 25 July 2003 amending the conditions for authorisation of a number of 
additives in feedingstuffs belonging to the group of trace elements (OJ L 187, 26.7.2003, p. 11) 
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Methods(s) of Analysis for natural mixture of dolomite plus magnesite and magnesium-
phyllosilicates. 
5. Comments from Member States. 
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Abbreviations 
AAS atomic absorption spectrophotometry 
ADFI average daily feed intake 
ADG average daily gain 
ADI average daily intake 
BW body weight 
CAS Chemical Abstracts Service 
CP Crude Protein 
CV Coefficient of variation 
DM  Dry matter 
EC European Commission 
EFSA European Food Safety Authority 
EURL European Union Reference Laboratory 
EINECS European Inventory of Existing Commercial Chemical Substances 
FEEDAP Panel on Additives and Products or Substances used in Animal Feed 
GLP Good laboratory practice 
HACCP hazard analysis and critical control points 
ICDD International Center for Diffraction Data 
MCHC mean corpuscular haemoglobin concentration 
MCV mean corpuscular volume 
ME Metabolisable energy  
MDMM Natural mixture of dolomite, magnesite, and magnesium-phyllosilicates  
(talc and chlorite) 
NE Net energy 
OECD Organisation for Economic Co-operation and Development 
PCBs  Polychlorinated biphenyl 
PCDD/F Polychlorinated dibenzodioxins/dibenzofurans 
TEQ Toxic equivalent 
WHO World Health Organisation  
XRD X-ray diffraction 
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Annex A – Executive Summary of the Evaluation Report of the European 
Union Reference Laboratory for Feed Additives on the 
Method(s) of Analysis for mixture of dolomite plus magnesite 
and magnesium-phyllosilicates  
In the current application, authorisation is sought under article 4(1) Fluidol, natural mixture of 
dolomite plus magnesite and magnesium-phyllosilicates (later referred as DMM), under the 
category/functional group and 1(i) 'technological additives'/'binders' and 'anticaking agents' according 
to the classification system of Annex I of Regulation (EC) No 1831/2003. The authorisation is sought 
for the use of the feed additive for all animal species. DMM is an odourless grey powder obtained by 
crushing and milling natural rocks. The feed additive consists mainly of dolomite, magnesite and 
magnesium-phyllosilicates and other minerals such as hydrated silicates. According to the Applicant, 
the feed additive contains a minimum of 40% of dolomite and magnesite. The feed additive is 
intended to be used in premixtures and feedingstuffs. The Applicant did not specify any maximum or 
minimum concentration of DMM in feedingstuffs but recommends a dosage of 0.5–2% for all animal 
species. 
For the determination of mineralogical composition of the feed additive the Applicant submitted 
experimental data obtained using X-ray diffraction (XRD) method. Furthermore, the chemical 
composition of the feed additive was characterised by the Applicant using atomic absorption 
spectrophotometry (AAS). Based on the experimental evidence provided, the EURL recommends for 
official control the two methods (XRD and AAS) for the characterisation of Fluidol. 
As the quantification of DMM in premixtures and feedingstuffs is not achievable experimentally, the 
EURL cannot recommend any method for official control in these matrices. 
Further testing or validation of the methods to be performed through the consortium of National 
Reference Laboratories as specified by article 10 (Commission Regulation (EC) No 378/2005) is not 
considered necessary. 
 
 
